S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|The Rosen Law Firm, P.A. Announces Proposed Class Action Settlement on Behalf of Purchasers of Common Stock of Catalyst Pharmaceutical Partners, Inc. -- CPRX|
|Catalyst Pharmaceuticals Announces Third Quarter 2014 Financial Results|
|Catalyst Pharmaceuticals to Present Top-Line Safety and Efficacy Results From Phase 3 Firdapse Trial at 139th Annual Meeting of the American Neurological Association|
|Catalyst Pharmaceuticals to Present Firdapse Phase 3 Trial Results at the 61st Annual Meeting of the American Association of Neuromuscular and Electrodiagnostic Medicine|
|Catalyst Pharmaceuticals Announces Proposed Settlement of Pending Securities Class Action Lawsuit|
|Catalyst Pharmaceuticals Appoints David J. Caponera as Vice President Patient Advocacy and Reimbursement|
|Catalyst Pharmaceuticals Announces Notice of Allowance of U.S. Patent Application for the Reduction or Elimination of Visual Field Defects by Treating Patients With CPP-115|
|Catalyst Pharmaceuticals to Present at the Piper Jaffray 26th Annual Healthcare Conference|
|Catalyst Pharmaceuticals Appoints David D. Muth, Executive Vice President, Chief Commercial Officer|
|Catalyst Pharmaceuticals Announces the Passing of Hubert E. Huckel, Co-Founder and Director|
Click above to view more mutual fund data and stats for cprx - Catalyst Pharmaceutical Partners Inc.